SUN PHARMA ADVANCED RESEARCH COMPANY
|
The Current P/S Ratio of SUN PHARMA ADVANCED RESEARCH COMPANY is 3.63.
| Share Price | ₹210.0 | May 22,2026 |
| Market Cap | ₹6,812.9 Cr | |
| Sales-TTM | ₹1,879.2 Cr | TTM-Consolidated Results |
| Price/Sales | 3.63x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of SUN PHARMA ADVANCED RESEARCH COMPANY
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹6,812.9 Cr] as on May 22,2026
(/) Sales [ ₹1,879.2 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 3.63x ]
Thus, for SUN PHARMA ADVANCED RESEARCH COMPANY , the investors are currently willing to pay '3.63 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of SUN PHARMA ADVANCED RESEARCH COMPANY !
The chart below summarizes the trend in P/S Ratio of SUN PHARMA ADVANCED RESEARCH COMPANY over the last five years.
Historical PS (Price/Sales) ratio chart of SUN PHARMA ADVANCED RESEARCH COMPANY
PS Ratio Performance Analysis for SUN PHARMA ADVANCED RESEARCH COMPANY
- SUN PHARMA ADVANCED RESEARCH COMPANY 's p/e ratio for fiscal years ending Mar2025 to Mar2023 averaged 83.41x.
- SUN PHARMA ADVANCED RESEARCH COMPANY 's operated at median p/e ratio of 66.93x from fiscal years ending March 2018 to 2022.
- Looking back at the last 3 fiscal years, SUN PHARMA ADVANCED RESEARCH COMPANY 's p/e ratio peaked in Mar2024 at 158.92x.
- SUN PHARMA ADVANCED RESEARCH COMPANY 's p/e ratio hit its five-year low in Mar2023 of 24.39x.
How does SUN PHARMA ADVANCED RESEARCH COMPANY 's P/S Ratio benchmark against top 10 peers in Business Support Industry?
| Peer Comparison (Business Support Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| SUN PHARMA ADVANCED RESEARCH COMPANY | 1,879.2 | 3.63 | 6,812.9 |
| SAGILITY LTD | 7,192.9 | 2.68 | 19,310.5 |
| SYNGENE INTERNATIONAL LTD | 3,738.7 | 4.99 | 18,639.4 |
| PRIME FOCUS LTD | 4,270.3 | 4.40 | 18,786.7 |
| INTERNATIONAL GEMOLOGICAL INSTITUTE LTD | 1,018.2 | 15.82 | 16,113.1 |
| INDEGENE LTD | 3,510.5 | 3.49 | 12,239.0 |
| NESCO LTD | 872.5 | 10.04 | 8,763.1 |
| LATENT VIEW ANALYTICS LTD | 1,060.2 | 6.36 | 6,747.8 |
| CMS INFO SYSTEMS LTD | 2,487.2 | 2.03 | 5,047.0 |
| SMARTWORKS COWORKING SPACES LTD | 1,795.8 | 2.86 | 5,144.7 |
| JUST DIAL LTD | 1,213.9 | 3.64 | 4,420.0 |
Business Support Industry Benchmark (Top 10) PS Analysis vs SUN PHARMA ADVANCED RESEARCH COMPANY 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.03x |
| Max industry PS | 15.82x |
| Median industry PS | 3.64x |
| Average industry PS | 5.45x |
You may also like the below Video Courses